COVID-19
Indiana life sciences leaders are tackling COVID-19 through drug development, lab testing, research and data. Indiana Life Sciences Innovators Working to Combat COVID-19
COVID-19
Indiana life sciences leaders are tackling COVID-19 through drug development, lab testing, research and data. Indiana Life Sciences Innovators Working to Combat COVID-19
BioCrossroads is Igniting IN life sciences. Our mission is to ignite the continued growth of Indiana’s robust life sciences industry.
BioCrossroads is Igniting IN life sciences. Our mission is to ignite the continued growth of Indiana’s robust life sciences industry.
ENGAGE IN
A Look at Indiana’s Emerging Radiopharmaceutical Industry
A cluster of radiopharmaceutical companies is growing in the greater Indianapolis area. In our last virtual Frameworx session on May 6th, we provided an overview of the field, discussed how it’s impacting the life sciences community, and showcased some of the major players in this space.
WE ARE IN
LIFE SCIENCES
BioCrossroads ignites Indiana’s diverse and robust life sciences industry.
Emergency Use Authorizations – vaccines, therapies, diagnostics and policy
John Christensen, MD, FAAP, FIDSA, FPIDS
M. Laura Parnas, PhD, DABCC
Ross Silverman, JD, MPH
BioCrossroads adds Lilly, Indiana Biosciences Research Institute executives to Board of Directors
BioCrossroads announces that Adrienne Brown, vice president of US Diabetes […]
Life Sciences Companies in Indiana by Employment
Indiana Life Sciences Capital: A Summary of 2019 Investments
An impressive $9.1 billion in capital was accessed by Indiana life sciences companies in 2019. The report details information on the types of funding, the companies who received capital, how much was funded, and the funders.
AXIS
AXIS is a new mentoring program focused on developing Indiana’s life sciences entrepreneurial talent.
INVEST IN
BioCrossroads has established itself as an important source of venture capital for Indiana’s life sciences industry through the formation of early-stage life sciences focused, return-driven investment funds.
